HER2 ENRICHED

Clinical trials for HER2 ENRICHED explained in plain language.

Never miss a new study

Get alerted when new HER2 ENRICHED trials appear

Sign up with your email to follow new studies for HER2 ENRICHED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Trial for advanced breast cancer withdrawn before starting

Disease control Terminated

This trial was planned to compare a newer drug (trastuzumab deruxtecan) against standard treatments for a specific type of advanced breast cancer that has spread. It aimed to see which approach was better at controlling the disease and delaying its progression. However, the trial…

Matched conditions: HER2 ENRICHED

Phase: PHASE3 • Sponsor: Danish Breast Cancer Cooperative Group • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

HER2 ENRICHED

Get alerted when new HER2 ENRICHED trials appear

Trial for advanced breast cancer withdrawn before starting